Biocan Novel Puppy, Lyophilisate and solvent for suspension for injection

Ima dovoljenje za promet

Canine parvovirus, type 2b, strain CPV-2b Bio 12/B, Live
Canine distemper virus, strain CDV Bio 11/A, Live

Prenes kot PDF

Informacije o zdravilu

Ime zdravila:

Biocan Novel Puppy, Lyophilisate and solvent for suspension for injection

Učinkovina:

Na voljo samo v English
Na voljo samo v English

Ciljne živalske vrste:

Na voljo samo v Bulgarian Spanish Czech Danish German Estonian Greek English French Italian Latvian Lithuanian Hungarian Dutch Romanian Finnish Swedish Icelandic Norwegian

Pot uporabe:

Subkutana uporaba

Podatki o zdravilu

Učinkovina / Jakost:

Na voljo samo v English

7.00

log10 50% tissue culture infectious dose

/

1.00

Dose
Na voljo samo v English

5.50

log10 50% tissue culture infectious dose

/

1.00

Dose

Farmacevtska oblika:

Liofilizat in vehikel za suspenzijo za injiciranje

Anatomsko-terapevtsko-kemična veterinarska oznaka klasifikacija zdravil, ki se uporabljajo v veterini (ATCvet):

QI07AD03

Pravni status za dobavo/izdajo zdravila:

Zdravilo, ki se izdaja na veterinarski recept

Status dovoljenja za promet z zdravilom:

Valid

Ima dovoljenje za promet v:

Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian

Opis ovojnine zdravila:

Na voljo samo v English
Na voljo samo v English
Na voljo samo v English

Dodatne informacije

Vrsta dovoljenja:

Na voljo samo v English French Croatian Italian Latvian Finnish Swedish Icelandic Norwegian

Pravna podlaga za izdajo dovoljenja za promet z zdravilom:

Na voljo samo v English Italian

Imetnik dovoljenja za promet z zdravilom:

Bioveta a.s.

Datum dovoljenja za promet z zdravilom:

9/03/2017

Proizvodna mesta, odgovorna za sproščanje serij:

Bioveta a.s.

Pristojni organ:

State Food And Veterinary Service

Številka dovoljenja za promet z zdravilom:

LT/2/17/2383/001-003

Datum spremembe statusa dovoljenja za promet:

27/02/2022

Referenčna država članica:

Na voljo samo v Spanish Czech German Estonian English French Italian Latvian Dutch Portuguese Slovak Swedish Icelandic Norwegian

Številka postopka:

CZ/V/0134/001

Zadevne države članice:

Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Croatian Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian Greek English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish German Estonian English French Italian Dutch Portuguese Slovak Finnish Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Italian Lithuanian Dutch Portuguese Romanian Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian
Na voljo samo v Spanish Czech German Estonian English French Italian Dutch Portuguese Slovak Swedish Icelandic Norwegian

Za poročila o domnevnih neželenih učinkih zdravil za uporabo v veterinaski medicini obiščite stran: www.adrreports.eu/vet

Dokumenti

Combined File of all Documents

Ta dokument ne obstaja v tem jeziku (slovenščina). Spodaj ga najdete v drugem jeziku.

Drugi jeziki (1)

Lithuanian (PDF)

Objavljeno na dan: 17/03/2026

Prenesi